This inventor holds 5 USPTO granted patents, plus 2 CIPO patents and 3 EPO patents. Top assignees: Cevec Pharmaceuticals Gmbh, Institut Pasteur, National Institute of Health and Medical Research. Active years: 1997-2016.
Location History:
- Wiesbaden, DE (1997 - 2016)
- Cologne, DE (2016)
Company Filing History:
3 out of 10 
2 out of 897 
2 out of 1,853 
Years Active: 1997-2016
Title: Christoph Volpers: Innovator in Human Cell Line Technology
Introduction
Christoph Volpers is a notable inventor based in Wiesbaden, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of permanent human cell lines. With a total of 5 patents to his name, Volpers has established himself as a key figure in his area of expertise.
Latest Patents
One of his latest patents is a method for the production of permanent human cell lines. This invention relates to a permanent human cell line that comprises a nucleic acid sequence for the adenoviral gene functions E1A and E1B, as well as the nucleic acid sequence for the SV40 large T-antigen or the Epstein-Barr virus (EBV) nuclear antigen 1 (EBNA-1). Furthermore, this patent outlines a method for the transient expression of recombinant polypeptides and proteins in the aforementioned permanent human cell line. Another patent by Volpers also focuses on the production of permanent human cell lines, detailing a method where isolated primary human cells are transfected simultaneously with a sequence that allows the expression of at least one cell-transforming factor and a sequence that allows the expression of at least one recombinant polypeptide.
Career Highlights
Throughout his career, Christoph Volpers has worked with prominent organizations in the biotechnology sector. Notably, he has been associated with Cevec Pharmaceuticals GmbH and Institut Pasteur. His work in these institutions has furthered advancements in cell line technology and recombinant protein expression.
Collaborations
Volpers has collaborated with several esteemed colleagues in his field, including Gudrun Schiedner and Gerard Orth. These partnerships have contributed to the success of his research and innovations.
Conclusion
Christoph Volpers is a distinguished inventor whose work in the development of permanent human cell lines has had a significant impact on biotechnology. His patents and collaborations reflect his commitment to advancing scientific knowledge and technology in this vital area.